18.11 USD
-0.06 (-0.33%)
Taking everything into account, DHCNL scores 2 out of 10 in our fundamental rating. DHCNL was compared to 127 industry peers in the Diversified REITs industry. DHCNL may be in some trouble as it scores bad on both profitability and health. DHCNL is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DHCNL had negative earnings in the past year.
DHCNL had a positive operating cash flow in the past year.
DHCNL had negative earnings in 4 of the past 5 years.
In multiple years DHCNL reported negative operating cash flow during the last 5 years.
1.2 Ratios
DHCNL has a Return On Assets of -7.52%. This is amonst the worse of the industry: DHCNL underperforms 89.76% of its industry peers.
Looking at the Return On Equity, with a value of -20.85%, DHCNL is doing worse than 84.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| ROIC | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 17.58%, DHCNL is not doing good in the industry: 94.49% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DHCNL has declined.
DHCNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
2. Health
2.1 Basic Checks
DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DHCNL has more shares outstanding
The number of shares outstanding for DHCNL has been increased compared to 5 years ago.
DHCNL has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.35, we must say that DHCNL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DHCNL (0.35) is comparable to the rest of the industry.
DHCNL has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.61, DHCNL is doing worse than 61.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.35 |
ROIC/WACCN/A
WACC6.74%
2.3 Liquidity
DHCNL has a Current Ratio of 6.66. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
DHCNL's Current ratio of 6.66 is amongst the best of the industry. DHCNL outperforms 96.06% of its industry peers.
A Quick Ratio of 6.66 indicates that DHCNL has no problem at all paying its short term obligations.
DHCNL has a better Quick ratio (6.66) than 96.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.66 | ||
| Quick Ratio | 6.66 |
3. Growth
3.1 Past
DHCNL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.32%.
DHCNL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.10%.
Measured over the past years, DHCNL shows a small growth in Revenue. The Revenue has been growing by 7.53% on average per year.
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
3.2 Future
DHCNL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.85% yearly.
The Revenue is expected to grow by 4.05% on average over the next years.
EPS Next Y-22.64%
EPS Next 2Y20.29%
EPS Next 3Y13.85%
EPS Next 5YN/A
Revenue Next Year4.4%
Revenue Next 2Y4.02%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DHCNL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DHCNL is valued expensively inside the industry as 93.70% of the companies are valued cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 29 |
4.3 Compensation for Growth
DHCNL's earnings are expected to grow with 13.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.29%
EPS Next 3Y13.85%
5. Dividend
5.1 Amount
DHCNL has a yearly dividend return of 0.82%, which is pretty low.
With a Dividend Yield of 0.82, DHCNL pays less dividend than the industry average, which is at 6.43. 92.13% of the companies listed in the same industry pay a better dividend than DHCNL!
With a Dividend Yield of 0.82, DHCNL pays less dividend than the S&P500 average, which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
5.2 History
The dividend of DHCNL decreases each year by -45.60%.
DHCNL has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of DHCNL are negative and hence is the payout ratio. DHCNL will probably not be able to sustain this dividend level.
DP-2.74%
EPS Next 2Y20.29%
EPS Next 3Y13.85%
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46
NASDAQ:DHCNL (12/29/2025, 4:30:01 PM)
18.11
-0.06 (-0.33%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners76.91%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap4.39B
Revenue(TTM)1.54B
Net Income(TTM)-352.11M
Analysts74.29
Price Target20.41 (12.7%)
Short Float %0.01%
Short Ratio1.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.74%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.08%
Min EPS beat(2)-213.15%
Max EPS beat(2)-71.02%
EPS beat(4)1
Avg EPS beat(4)-46.14%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)2
Avg EPS beat(8)-24.79%
EPS beat(12)4
Avg EPS beat(12)-9.26%
EPS beat(16)4
Avg EPS beat(16)-20.93%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)-0.57%
PT rev (3m)23.91%
EPS NQ rev (1m)7.89%
EPS NQ rev (3m)14.63%
EPS NY rev (1m)-54.55%
EPS NY rev (3m)-53.61%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)1.04%
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.85 | ||
| P/FCF | N/A | ||
| P/OCF | 234.67 | ||
| P/B | 2.6 | ||
| P/tB | 2.6 | ||
| EV/EBITDA | 29 |
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.08
OCFY0.43%
SpS6.35
BVpS6.97
TBVpS6.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.58% | ||
| FCFM | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.41 | ||
| Cap/Depr | 65.29% | ||
| Cap/Sales | 11.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 7.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.66 | ||
| Quick Ratio | 6.66 | ||
| Altman-Z | 0.35 |
F-Score6
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
EPS Next Y-22.64%
EPS Next 2Y20.29%
EPS Next 3Y13.85%
EPS Next 5YN/A
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
Revenue Next Year4.4%
Revenue Next 2Y4.02%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year382.47%
EBIT Next 3Y74.06%
EBIT Next 5YN/A
FCF growth 1Y38.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.8%
OCF growth 3YN/A
OCF growth 5Y-15.84%
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 / DHCNL FAQ
What is the ChartMill fundamental rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?
ChartMill assigns a fundamental rating of 2 / 10 to DHCNL.
What is the valuation status for DHCNL stock?
ChartMill assigns a valuation rating of 0 / 10 to DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL). This can be considered as Overvalued.
Can you provide the profitability details for DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46?
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) has a profitability rating of 1 / 10.
Can you provide the dividend sustainability for DHCNL stock?
The dividend rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is 1 / 10 and the dividend payout ratio is -2.74%.